Document is current
Any future updates will be listed below
-
Authors
Bapat, Sagar P. https://orcid.org/0000-0002-4402-1511
Whitty, Caroline
Mowery, Cody T.
Liang, Yuqiong
Yoo, Arum
Jiang, Zewen https://orcid.org/0000-0002-3852-8666
Peters, Michael C.
Zhang, Ling-juan https://orcid.org/0000-0001-6937-4578
Vogel, Ian
Zhou, Carmen
Nguyen, Vinh Q.
Li, Zhongmei
Chang, Christina
Zhu, Wandi S.
Hastie, Annette T.
He, Helen
Ren, Xin
Qiu, Wenli
Gayer, Sarah G. https://orcid.org/0000-0002-1032-5971
Liu, Chang
Choi, Eun Jung
Fassett, Marlys https://orcid.org/0000-0002-5750-1928
Cohen, Jarish N.
Sturgill, Jamie L.
Crotty Alexander, Laura E. https://orcid.org/0000-0002-5091-2660
Suh, Jae Myoung
Liddle, Christopher https://orcid.org/0000-0003-3936-6790
Atkins, Annette R.
Yu, Ruth T. https://orcid.org/0000-0002-9527-9627
Downes, Michael
Liu, Sihao
Nikolajczyk, Barbara S. https://orcid.org/0000-0001-5647-5740
Lee, In-Kyu https://orcid.org/0000-0002-1655-0985
Guttman-Yassky, Emma https://orcid.org/0000-0002-9363-324X
Ansel, K. Mark https://orcid.org/0000-0003-4840-9879
Woodruff, Prescott G.
Fahy, John V.
Sheppard, Dean https://orcid.org/0000-0002-6277-2036
Gallo, Richard L. https://orcid.org/0000-0002-1401-7861
Ye, Chun Jimmie https://orcid.org/0000-0001-6560-3783
Evans, Ronald M. https://orcid.org/0000-0002-9986-5965
Zheng, Ye https://orcid.org/0000-0001-5012-4309
Marson, Alexander https://orcid.org/0000-0002-2734-5776
- License Information
-
More Information
Article History
Received: 18 March 2021
Accepted: 8 February 2022
First Online: 30 March 2022
Competing interests
: E.G.Y. has received institutional research funds from and is a consultant for Abbvie, Almirall, Amgen, Asana Biosciences, AstraZeneca, Boerhinger-Ingelhiem, Cara Therapeutics, Celgene, Elli Lilly, Galderma, Glenmark/Ichnos Sciences, Janssen, Kyowa Kirin, Leo Pharma, Pfizer, Regeneron, and UCB. E.G.Y. has received institutional research funds from AnaptysBio, Innovaderm, KAO, Kiniksa, Novan, Novartis, and Ralexar. E.G.Y. is a consultant for Arena, Aslan Pharmaceuticals, Bristol-Myers Squibb, Connect Pharma, EMD Serono, Evidera, Incyte, Pandion Therapeutics, RAPT Therapeutics, Sanofi, SATO Pharmaceutical, Siolta Therapeutics, Target Pharma Solutions, and Ventyx Biosciences. R.L.G. is a consultant and has equity interest in MatriSys Biosciences and Sente Inc. C.J.Y. is a Scientific Advisory Board member for and holds equity in Related Sciences and ImmunAI, a consultant for and holds equity in Maze Therapeutics, and a consultant for TReX Bio. C.J.Y. has received research support from Chan Zuckerberg Initiative, Chan Zuckerberg Biohub, and Genentech. A.M. is a compensated cofounder, member of the boards of directors and a member of the scientific advisory boards of Spotlight Therapeutics and Arsenal Biosciences. A.M. is a cofounder, member of the boards of directors and a member of the scientific advisory board of Survey Genomics. A.M. is a compensated member of the scientific advisory board of NewLimit. A.M. owns stock in Arsenal Biosciences, Spotlight Therapeutics, NewLimit, Survey Genomics, PACT Pharma, and Merck. A.M. has received fees from PACT Pharma, Juno Therapeutics, Trizell, Vertex, Merck, Amgen, Genentech, AlphaSights, 23andMe, ALDA, Rupert Case Management and Bernstein. A.M. is an investor in and informal advisor to Offline Ventures and a client of EPIQ. The Marson lab has received research support from Juno Therapeutics, Epinomics, Sanofi, GlaxoSmithKline, Gilead and Anthem.
